MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.340
-0.030 (-2.19%)
At close: Jun 2, 2026, 4:00 PM EDT
1.340
0.00 (0.00%)
After-hours: Jun 2, 2026, 4:10 PM EDT
MediciNova Market Cap
MediciNova has a market cap or net worth of $65.96 million as of June 2, 2026. Its market cap has decreased by -3.29% in one year.
Market Cap
65.96M
Enterprise Value
40.27M
1-Year Change
-3.29%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since December 8, 2006, MediciNova's market cap has decreased from $124.80M to $65.96M, a decrease of -47.15%. That is a compound annual growth rate of -3.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 67.40M | 4.82% |
| Dec 31, 2025 | 64.30M | -37.57% |
| Dec 31, 2024 | 103.00M | 39.95% |
| Dec 29, 2023 | 73.60M | -26.77% |
| Dec 30, 2022 | 100.50M | -23.52% |
| Dec 31, 2021 | 131.40M | -44.39% |
| Dec 31, 2020 | 236.30M | -20.03% |
| Dec 31, 2019 | 295.50M | -13.65% |
| Dec 31, 2018 | 342.20M | 46.49% |
| Dec 29, 2017 | 233.60M | 12.31% |
| Dec 30, 2016 | 208.00M | 95.67% |
| Dec 31, 2015 | 106.30M | 44.43% |
| Dec 31, 2014 | 73.60M | 53.65% |
| Dec 31, 2013 | 47.90M | 69.86% |
| Dec 31, 2012 | 28.20M | 3.30% |
| Dec 30, 2011 | 27.30M | -53.41% |
| Dec 31, 2010 | 58.60M | -31.22% |
| Dec 31, 2009 | 85.20M | 346.07% |
| Dec 31, 2008 | 19.10M | -65.27% |
| Dec 31, 2007 | 55.00M | -59.85% |
| Dec 29, 2006 | 137.00M | 9.78% |
| Dec 8, 2006 | 124.80M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 72.56M |
| Filana Therapeutics | 71.98M |
| BeyondSpring | 70.31M |
| Alterity Therapeutics | 69.97M |
| iBio, Inc. | 68.31M |
| Acrivon Therapeutics | 66.77M |
| TScan Therapeutics | 66.00M |
| PMV Pharmaceuticals | 65.60M |